ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,606Medicare Part D Prescriptions Filled, Including Refills

Rank: 74 out of 337

$418K Total Retail Price of All Prescriptions

Rank: 98 out of 337

484 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
21% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Rhode Island
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 484 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

10% of this provider’s 484 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

1% of this provider’s 7,787 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$44 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Rhode Island
ATENOLOL 572 509 1 10
LISINOPRIL 426 384 2 2
SIMVASTATIN 412 359 3 1
LEVOTHYROXINE SODIUM 391 315 4 5
FUROSEMIDE 305 202 5 8
HYDROCHLOROTHIAZIDE 299 262 6 9
AMLODIPINE BESYLATE 295 265 7 3
OMEPRAZOLE 275 225 8 4
HYDROCODONE-ACETAMINOPHEN 214 120 S3 9 13
ATORVASTATIN CALCIUM 209 152 10 7
METFORMIN HCL 206 172 11 12
METOPROLOL TARTRATE 192 179 12 6
WARFARIN SODIUM 169 153 13 11
ZOLPIDEM TARTRATE 148 124 14 23
TRIAMTERENE-HCTZ 132 129 15 39
LOVASTATIN 126 114 16 24
ALLOPURINOL 123 108 17 28
PAROXETINE HCL 93 76 18 46
CITALOPRAM HBR 90 90 19 17
AZITHROMYCIN 86 75 20 51
LOSARTAN POTASSIUM 86 83 20 15
PRAVASTATIN SODIUM 83 77 22 14
DONEPEZIL HCL 82 82 23 22
NEXIUM 81 41 24 56
OXYCODONE HCL 77 43 S2 25 63
PROAIR HFA 76 32 26 38
ALENDRONATE SODIUM 75 75 27 19
METOPROLOL SUCCINATE 71 71 28 21
FLUOXETINE HCL 69 46 29 57
AMITRIPTYLINE HCL 66 36 R 30 75
SERTRALINE HCL 65 40 31 18
CLOPIDOGREL 64 64 32 42
TRAZODONE HCL 60 47 33 16
DIOVAN 58 46 34 26
DOXAZOSIN MESYLATE 58 55 34 68
GLIPIZIDE XL 56 55 36 123
GLIPIZIDE ER 56 56 36 69
TAMSULOSIN HCL 55 42 38 25
SULINDAC 55 55 38 308
CIPROFLOXACIN HCL 53 50 40 71
PREDNISONE 52 51 41 40
SYNTHROID 52 51 41 41
CARISOPRODOL 51 0 R 43 180
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 2, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.